Home › Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research
 

Keywords :   


Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research

2013-01-07 07:29:27| drugdiscoveryonline News Articles

Cellular Dynamics International, Inc. (CDI) recently announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells.

Tags: research agreement human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »